Evidence map›Paper›PMID 18364393›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2008

Culturing of human peripheral blood cells reveals unsuspected lymphocyte responses relevant to HIV disease.

Bita Sahaf, Kondala Atkuri, Kartoosh Heydari, Meena Malipatlolla, Jay Rappaport, Emmanuel Regulier, Leonard A Herzenberg, Leonore A Herzenberg

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. The in vitro treatment of mesenchymal stem cells for colorectal cancer cells.Medical oncology (Northwood, London, England) · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Our NIH years: a confluence of beginnings.The Journal of biological chemistry · 2013
    Article
  12. Article
  13. Glut1-mediated glucose transport regulates HIV infection.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Bita SahafDepartment of Genetics and Department of Pediatrics, Division of Stem Cell Transplantation, Stanford University School of Medicine, Stanford, CA 94305, USA.
Kondala Atkuri
Kartoosh Heydari
Meena Malipatlolla
Jay Rappaport
Emmanuel Regulier
Leonard A Herzenberg
Leonore A Herzenberg
Temple University · USStanford University · US

Funding

Do antibodies to HIV-Tat regulate redox status in HIV?R21AI064104 · NIAID · STANFORD UNIVERSITY · PI HERZENBERG, LEONORE A. · 2006 to 2007
$423k
NIAID NIH HHS AI 064104NIAID NIH HHS R21 AI064104
6 · The paper itself

Abstract

Recombinant HIV-Tat (Tat) induces extensive apoptosis in peripheral blood mononuclear cells (PBMCs) cultured in typical CO2 incubators, which are equilibrated with air (21% O2). However, as we show here, Tat apoptosis induction fails in PBMCs cultured at physiological oxygen levels (5% O2). Under these conditions, Tat induces PBMCs to divide, efficiently primes them for HIV infection, and supports virus production by the infected cells. Furthermore, Tat takes only 2 h to prime PBMCs under these conditions. In contrast, PHA/IL-2, which is widely used to prime cells for HIV infection, takes 2-3 days. These findings strongly recommend culturing primary cells at physiological oxygen levels. In addition, they suggest HIV-Tat as a key regulator of HIV disease progression.

Indexed as

ApoptosisCell Culture TechniquesCell DivisionDisease ProgressionGene Products, tatHIVHIV InfectionsHumansInterleukin-2LymphocytesOxygenTime FactorsVirus ReplicationGene Products, tatInterleukin-2Oxygen

Identifiers

PMID18364393
PMCPMC2278183
OpenAlexW2125048387

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.